Literature DB >> 1948455

[Prognosis of life in polymyositis/dermatomyositis].

K Murabayashi1, E Saito, S Okada, T Ogawa, M Kinoshita.   

Abstract

Although substantial patients are dead in the course of PM/DM, little papers have precisely investigated the cause of death and factors which may relate to death in PM/DM. The purpose of the present study is to evaluate the prognosis for life, causes of death and risk factors for life in PM/DM. Clinical records of 76 adult PM/DM patients were retrospectively reviewed. Seven patients died of associated malignancy. Five-year survival rate was 69.7% in PM/DM patients without malignancy. During the last 24 years, there was no significant change in survival rate. Among causes of death in 19 cases without malignancy, 7 cases died of respiratory failure and 7 patients died of cardiac involvement. There seems to be two types of pulmonary involvement causing respiratory failure; i.e. acute interstitial pneumonitis and chronic interstitial pneumonitis. In the former cases, the courses were very rapid, and patients died during 4 months after appearance of the first symptom. Risk factors were chosen by comparing clinical manifestation in dead patients with those in control subject. Control subjects were selected from non-dead patients by matching with sex, age, and duration after start of the first therapy. Acute onset disease, fever, arthritis, hypergammaglobulinemia, elevated ESR (greater than or equal to 30 mm/hr), lung fibrosis, and heart involvement are risk factors for life.

Entities:  

Mesh:

Year:  1991        PMID: 1948455

Source DB:  PubMed          Journal:  Ryumachi        ISSN: 0300-9157


  2 in total

1.  Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: A retrospective case-control study.

Authors:  Chanyuan Wu; Qian Wang; Linrong He; Enhao Yang; Xiaofeng Zeng
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

2.  Polymyositis/dermatomyositis is a potential risk factor for acute respiratory failure: a pulmonary heart disease.

Authors:  Shih-Huei Syue; Yi-Hua Chang; Pei-Ju Shih; Cheng-Li Lin; Jun-Jun Yeh; Chia-Hung Kao
Journal:  Ann Transl Med       Date:  2020-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.